Navigation Links
Thermo Fisher Scientific Acquires Leader in Micro-Volume Spectrophotometers, NanoDrop Technologies
Date:10/9/2007

Scientific (NYSE: TMO) is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With an annual revenue rate of more than $9 billion, we employ 30,000 people and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike. Visit http://www.thermofisher.com.

Media Contact Information:

Lori Gorski

Phone: 781-622-1242

E-mail: lori.gorski@thermofisher.com

Website: http://www.thermofisher.com

Investor Contact Information:

Ken Apicerno

Phone: 781-622-1111

E-mail:

SOURCE Thermo Fisher Scientific Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Normalizing cDNA libraries using the EppendorfThermomixer
2. Rapid PCR* Using Active Tube Temperature Control On Thermos PCR Machines
3. A simple method to sequence from bacterial colonies using [a-33P] radiolabeled ddNTPs and Thermo Sequenase
4. Fisher Biosciences contracts with Madison-based GenTel BioSurfaces
5. UW-Madisons Beebe wins scientific award
6. Researchers say scientific reporting needs more perspective, less hype
7. Wisconsin stands at the center of scientific efforts to avert flu epidemics
8. Growth prompts new location for scientific instrument manufacturer
9. UW stem cell guru outlines scientific and political future
10. Wisconsin biotech sector featured in scientific magazine
11. Scientific Protein Laboratories Acquired by New York firm

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... , SEATTLE, Nov. 20 C...) announced today that the Ninth Circuit Court of ...uled that CTI should be allowed to pursue all of i... back to the District Court for trial. CTI filed ...hird-party reimbursement consultant for CTI,s prod...
(Date:11/19/2009)... COPENHAGEN, Nov. 19 Danish Prince...ellulosic ethanol plant in Kalundborg, Denmark, on...e world,s first and largest 2nd generation ethanol...se enzymes are used in the plant,s innovative proc...sion of Danisco, was the first to market with comm...
(Date:11/19/2009)..., NEW YORK, Nov. 19 NeoS... it has sent the following letter to its sharehold...ber 30, 2009, of China Biopharmaceuticals Holdings...mpany based in the People,s Republic of China. The...n Suzhou Eyre Pharmaceutical Co. Ltd., CHBP,s prim...
(Date:11/19/2009)..., MONTREAL, Nov. 19 /PRNewswire/ - Aegera Therapeu...patient in a randomized Phase 2B study of AEG35156...velopment for multiple oncology indications. ,,...se 2 Study of the X-Linked Inhibitor of Apoptosis ...h High-dose Cytarabine and Idarubicin in AML Follo...
Breaking Biology Technology:Cell Therapeutics Wins Federal Appeal to Pursue $22.8 Million Claim Against The Lash Group 2DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2
... May 7 Cadence Pharmaceuticals, Inc. (Nasdaq: C...icensing, developing and commercializing proprieta...ospital setting, today reported financial results ...We have now completed the clinical development pro...on of intravenous acetaminophen for the treatment ...
...Calif., May 7 AutoImmune Inc. (OTC Bulletin Board...$0.01 per share basic and diluted, for the three m...ss of $107,000, or $0.01 per share basic and dilut... of March 31, 2009, the Company reported $8.5 mill...ount reported as of December 31, 2008. , , Chair...
...eeded to train workforce, stimulate economy , , ...eiled its Fiscal Year 2010 budget request, proposi...d Technical Education Act (Perkins Act) at $1.3 bi...deral funding that supports local education progra...The Association for Career and Technical Education...
Other Biology Technology:Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 2Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 3Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 4Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 5Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 6Cadence Pharmaceuticals Reports First Quarter 2009 Financial Results 7AutoImmune Inc. Reports 2009 First Quarter Financial Results 2AutoImmune Inc. Reports 2009 First Quarter Financial Results 3AutoImmune Inc. Reports 2009 First Quarter Financial Results 4Obama Budget Level Funds Career Technical Education 2Obama Budget Level Funds Career Technical Education 3
(Date:11/19/2009)...ate fungus for food, have many remarkable qualitie...nt farmers, like their human counterparts, depend ...grow. The finding, reported this week (Nov. 20) in...nown symbiosis between ants and bacteria and provi... dominate the American tropics and subtropics. , ...
(Date:11/19/2009)... multi-institutional effort co-led by three Cold S...ed today in publication of a landmark series of pa...dented detail the DNA sequence of maize ( Zea mays...rth American consumers, is one of the world,s most...al crop grown in the United States, representing $...
(Date:11/19/2009)...ainable farming, initially adopted to preserve soi...role in maintaining a healthy climate, according t...dge and Los Alamos national laboratories. , ORNL...tial of the earth,s soils to sequester carbon, wit...ould greatly reduce U.S. carbon emissions by as mu...
Breaking Biology News(10 mins):Like humans, ants use bacteria to make their gardens grow 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 4ORNL, Los Alamos pioneer new approach to assist scientists, farmers 2ORNL, Los Alamos pioneer new approach to assist scientists, farmers 3Sex Hormone Protein May Predict Type 2 Diabetes 53775 1Sex Hormone Protein May Predict Type 2 Diabetes 53775 2Sex Hormone Protein May Predict Type 2 Diabetes 53775 3PDI Reports 2009 Second Quarter Financial Results 13399 1PDI Reports 2009 Second Quarter Financial Results 13399 2PDI Reports 2009 Second Quarter Financial Results 13399 3PDI Reports 2009 Second Quarter Financial Results 13399 4PDI Reports 2009 Second Quarter Financial Results 13399 5PDI Reports 2009 Second Quarter Financial Results 13399 6PDI Reports 2009 Second Quarter Financial Results 13399 7PDI Reports 2009 Second Quarter Financial Results 13399 8PDI Reports 2009 Second Quarter Financial Results 13399 9Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results 13396 1Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results 13396 2Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results 13396 3Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results 13396 4Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results 13396 5Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results 13396 6Cadence Pharmaceuticals Reports Second Quarter 2009 Financial Results 13396 7
...if. Oct. 6, 2008 Complete Genomics Inc., a third... announced its formal launch as the world,s first ...rvices. , The company, which was established in ...rom a 32,000-square-foot facility near San Francis...nomics has been reinventing the process of DNA seq...
...wa researchers and collaborators have found, in a ...y contributes to one in five cases of isolated cle... been associated with cleft lip alone, rather than...insight on a previously unknown genetic mechanism ...on and treatment of cleft lip, which affects more ...
...IMMEDIATE RELEASE , New material could speed deve...rs , Researchers in Greece report design of a ne...f Energy (DOE) 2010 goals for hydrogen storage and... hydrogen-powered vehicles. Their study on a way o...heduled for the Oct. 8 issue of ACS, Nano Letters...
Other Biology News:Complete Genomics launches, becomes world's first large-scale human genome sequencing company 2Complete Genomics launches, becomes world's first large-scale human genome sequencing company 3Complete Genomics launches, becomes world's first large-scale human genome sequencing company 4Study finds genetic variant plays role in cleft lip 2Study finds genetic variant plays role in cleft lip 3American Chemical Society's Weekly PressPac 2American Chemical Society's Weekly PressPac 3American Chemical Society's Weekly PressPac 4American Chemical Society's Weekly PressPac 5American Chemical Society's Weekly PressPac 6American Chemical Society's Weekly PressPac 7American Chemical Society's Weekly PressPac 8
Anti-Neurotensin Receptor Monoclonal Antibody, Unconjugated , Clone B-N6 from Cell Sciences
Goat Anti-Human HNF4 Polyclonal Antibody, Unconjugated from Abcam
Goat Anti-Human SART1 Polyclonal Antibody, Unconjugated from Abcam
Mouse Anti-IkappaB-alpha Monoclonal Antibody, Unconjugated, Clone 112B2 from Cell Signaling Technology
Biology Products: